AHFS Drug Information | Mobile App


AHFS Drug Information

2017

Editor(s): Gerald K. McEvoy, Pharm.D

Publisher: American Society of Health-System Pharmacists

ISBN 13: 978-1585285587



Description At A Glance

AHFS DI remains the compendium that offers insight into the evidence behind the answers. Approximately 1400 monographs cover information on indications, dosage and administration, contraindications, side effects, drug interactions, pharmacology and pharmacokinetics, chemistry and stability, and more.

AHFS Drug Information with extensive updated information on everything from treatment of hypertension to hepatitis C, AHFS® Drug Information™, 2017 Edition is a necessary addition to your pharmacy’s resources.

With content supported by more than 86,000 total references and reviewed by over 500 professionals, AHFS DI® helps you protect your patients and your business. The only print compendium designated by the U.S. Congress, AHFS DI® 2017 is also the only reference published by a professional and scientific society—ensuring it is the most authoritative and best-selling reference trusted by pharmacists for 59 years.

AHFSI DI® contains the most trustworthy drug information available--all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.

Updates for this edition include:
  • Expanded and revised content throughout, featuring critical new monograph updates every year
  • Important updated monographs and references related to revised therapeutic guidelines, including revised recommendations for the treatment of HIV infections in adult and pediatric patients
  • Newly published information on breakthrough oncology drugs approved as part of the FDA’s
  • accelerated approval program
  • Dedicated coverage to orphan products
  • Interactions, adverse reactions, cautions, and more
  • Therapeutic recommendations supported by evidence from primary research
  • Preparations, chemistry, and stability
  • Pharmacology and pharmacokinetics
  • Prescription, OTC, ophthalmic and dermatologic drugs
  • Extensive off-label uses and dosing options
  • Vaccines and other immunizing agents
{ahfs-di17:3225}

Your Voice

By Kim Havard
Your chat executives are very unpressured and down to earth. I actually had to use the service twice for the same issue and had the pleasure of chatting with different executives. They both went out of their way to help me and I am deeply appreciate it.

Share Via

KEEP IN TOUCH

     


Copyright © 2017. All rights reserved. Skyscape® is the registered trademark of Skyscape Medpresso, Inc.
All other trademarks, service marks and registrations are the intellectual properties of their respective owners.